Clinical Study of IBI362 in Healthy Chinese Male Subjects

Condition:   Overweight/Obesity Interventions:   Drug: IBI362 liquid formulation;   Drug: IBI362 lyophilized powder Sponsor:   Innovent Biologics (Suzhou) Co. Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials